MedPath

Cabinet All Day Allergy Relief

Cabinet All Day Allergy Relief Cetirizine Hydrochloride

Approved
Approval ID

889316bc-5f98-426a-9750-2fdb0c427408

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 7, 2025

Manufacturers
FDA

Cabinet Health P.B.C.

DUNS: 117102391

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CETIRIZINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code82725-3103
Application NumberANDA077829
Product Classification
M
Marketing Category
C73584
G
Generic Name
CETIRIZINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateApril 7, 2025
FDA Product Classification

INGREDIENTS (8)

HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
CETIRIZINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 1
Code: 64O047KTOA
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cabinet All Day Allergy Relief - FDA Drug Approval Details